Details of the Drug Reposition

General Information of This Drug (ID: DM4HK8Z)

• Drug Name: ASTX727 (DM4HK8Z)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic myelogenous leukaemia	DIS0301E	2A20.0	Phase 3	[1]
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 3	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)